F. Litvack et al., CURRENT STATUS AND POTENTIAL APPLICATIONS OF THE HARTS REMOVABLE STENT, Journal of interventional cardiology, 7(2), 1994, pp. 165-175
Permanent intracoronary stents have demonstrated considerable efficacy
in the treatment of PTCA-induced abrupt arterial occlusion, suboptima
l dilatation, and restenosis. Despite their benefit, permanent stents
have significant limitations including subacute thrombosis, need for a
nticoagulation with resultant vascular complications, prolonged hospit
alization, and high costs. Temporary stents have the potential for ach
ieving many of the beneficial effects of permanent stenting without so
me of the iatrogenic complications. The HARTS (Heat Activated Removabl
e Temporary Stent) removable stent employs the shape memory alloy Niti
nol, and has the properties of being balloon deployable, but recoverab
le to a preset ''memory'' shape by heating it with warmed crystalloid
solution, Preclinical experience first with a wire stent design and mo
re recently with a slotted tubular design, has demonstrated the feasib
ility of implanting and recovering the HARTS device. Speculative appli
cations of this technology include: treatment of acute postangioplasty
occlusion and suboptimal angioplasty results; ''stentoplasty''-the ap
plication of a temporary stent for several hours at the time of a prim
ary angioplasty; and reduction of restenosis rate by inhibition of ela
stic recoil following short-term (hours) stenting. Further, the HARTS
device may be an important vehicle for local delivery of drugs or othe
r biologically active agents to the arterial wall. All research to dat
e has been preclinical and controlled clinical trials will be necessar
y to define the safety, efficacy, and potential applications of the HA
RTS removable stent.